Science Explorer Back to mapMap
Discussion
Company · Beverly · United States

CytoCure (United States)

cytocure.comROR OpenAlex
Research works
13
▲ 327% vs 2018-21
Citations
261
20.7 per fractional work
Top-10% rate
9.4%
all institutions 10.0%
Open access
45%
world 40%
International
44%
world 18%
CytoCure (United States)

Not ranked overall: CytoCure (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does CytoCure (United States) work in?

In all years, 53% of research at CytoCure (United States) is in Life Sciences, 45% in Health Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (27%), Immunology and Microbiology (25%). It does 2.0× the world's share of Life Sciences.

Life Sciences: 7 fractional works · 52.7% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 27.4% of its workMolecular Biology: 3 fractional works · 27.4% of its workImmunology and Microbiology: 3 fractional works · 24.7% of its workImmunology: 3 fractional works · 23.2% of its workMicrobiology: 0 fractional works · 0.9% of its workParasitology: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workHealth Sciences: 6 fractional works · 44.7% of its workMedicine: 6 fractional works · 44.7% of its workOncology: 3 fractional works · 22.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 8.6% of its workGastroenterology: 0 fractional works · 3.5% of its workEpidemiology: 0 fractional works · 2.6% of its workSurgery: 0 fractional works · 2.2% of its workPathology and Forensic Medicine: 0 fractional works · 2.0% of its workImmunology and Allergy: 0 fractional works · 1.4% of its workPhysiology: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.6% of its workPhysical Sciences: 0 fractional works · 2.6% of its workPhysics and Astronomy: 0 fractional works · 2.6% of its workAstronomy and Astrophysics: 0 fractional works · 2.6% of its workALL ITS WORKCytoCure (UnitedStates)13fractional works, all years
Life Sciences53%Physical Sciences3%Health Sciences45%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology327.4%
    2. Immunology and Microbiology324.7%
    3. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Medicine644.7%
    1. Physics and Astronomy02.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Who are the top researchers at CytoCure (United States)?

Ranked on the quality score, Estelle E. Newton lead among researchers whose main affiliation is CytoCure (United States).

  1. 1 Estelle E. Newton United States · #2,073,283 worldwide 683 citations · 20 works
All ranked researchers at CytoCure (United States)

What are the most cited papers from CytoCure (United States)?

The most cited paper from CytoCure (United States) is "Role of the Mitogen-Activated Protein Kinase Signaling Pathway in the Regulation of Human Melanocytic Antigen Expression" (Michihiro Kono, Ian S. Dunn, Paul J. Durda et al., 2006), with 143 citations. Next come "Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders" (89) and "The role of IL-15 in gastrointestinal diseases: A bridge between innate and adaptive immune response" (89).

Most cited papers
#PaperReleasedCitations
1 Role of the Mitogen-Activated Protein Kinase Signaling Pathway in the Regulation of Human Melanocytic Antigen Expression Michihiro Kono, Ian S. Dunn, Paul J. Durda et al. · Molecular Cancer Research Open access Oct 2006 143
2 Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders Danilo Pagliari, Angela Saviano, Estelle E. Newton et al. · Mediators of Inflammation Open access 2018 89
3 The role of IL-15 in gastrointestinal diseases: A bridge between innate and adaptive immune response Danilo Pagliari, Rossella Cianci, Simona Frosali et al. · Cytokine & Growth Factor Reviews Review 21 Jun 2013 89
4 Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease Stefano Bibbò, Gianluca Ianiro, Maria Pina Dore et al. · Mediators of Inflammation Open access 2018 87
5 The Importance of Complying with Vaccination Protocols in Developed Countries: “Anti-Vax” Hysteria and the Spread of Severe Preventable Diseases Franco Pandolfi, Laura Franza, Laura Todi et al. · Current Medicinal Chemistry 18 May 2018 62
All 17 most cited papers, with filters and sorting

Which research topics does CytoCure (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, T-cell and B-cell Immunology, Advanced Biosensing Techniques and Applications and Monoclonal and Polyclonal Antibodies Research.

CAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksT-cell and B-cell Immuno…1T-cell and B-cell Immunology: 1 fractional worksAdvanced Biosensing Techniques and Applications: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksImmunodeficiency and Autoimmune Disorders: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
OncologyImmunologyMolecular BiologyRadiology, Nuclear Medicine and Imaging

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 1 works
  2. 2 T-cell and B-cell Immunology Immunology 1 works
  3. 3 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.3%not open54.7%

World: 40% of research is openly available.

with international co-authors44.5%domestic only55.5%

World: 18% is written across borders.

How has CytoCure (United States)'s research output changed?

Output in 2022-2025 was 327% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is CytoCure (United States) as a percentage of every work published that year, 0.000028% in 2018.

still counting0.000050%0.00010%CytoCure (United States)0.000085% in 202520102020

Fractional works of CytoCure (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Beverly

All research institutions in Beverly

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about CytoCure (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.